Novozymes A/S (OTCMKTS:NVZMY) Sees Significant Growth in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) saw a large growth in short interest in July. As of July 15th, there was short interest totaling 26,584 shares, a growth of 87.2% from the June 30th total of 14,203 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 76,138 shares, the short-interest ratio is currently 0.3 days.

Novozymes A/S Price Performance

OTCMKTS:NVZMY opened at $65.04 on Friday. Novozymes A/S has a one year low of $49.90 and a one year high of $66.82. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.67. The stock has a market cap of $26.96 billion, a PE ratio of 43.95, a P/E/G ratio of 3.08 and a beta of 0.92. The stock has a 50 day moving average price of $61.67 and a 200 day moving average price of $60.48.

Novozymes A/S (OTCMKTS:NVZMY) last released its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Novozymes A/S had a return on equity of 6.52% and a net margin of 14.22%. Equities research analysts expect that Novozymes A/S will post 2.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on NVZMY. Kepler Capital Markets raised shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Zacks Research raised shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Novozymes A/S has an average rating of “Buy”.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).